HB 6669 Summary

• Establishes a Drug Discount Card Program and requires the Comptroller to study centralizing state drug purchasing across agencies and public entities to lower prescription drug costs.

• Requires pharmaceutical manufacturers employing sales representatives to register with the Department of Consumer Protection, maintain lists of representatives, and disclose drug list prices and efficacy information variation by race/ethnicity to healthcare providers.

• Restricts hospital facility fees by prohibiting charges for off-campus outpatient services using evaluation/management codes and banning such charges on-campus beginning July 1, 2024, with limited exceptions for emergency departments and specific services.

• Prohibits health insurance contracts from containing all-or-nothing clauses, anti-steering clauses, anti-tiering clauses, and gag clauses that restrict provider networks, price disclosure, or patient choice effective July 1, 2024.

• Requires pharmacy benefit managers to treat 340B covered entities equally regarding reimbursement rates and prohibits discrimination or retaliation based on 340B program participation starting January 1, 2024.